139 related articles for article (PubMed ID: 34727830)
1. Fish evaluation of additional cytogenetic aberrations and hyperdiploidy in childhood Burkitt lymphoma.
Avgerinou G; Stefanaki K; Liapis K; Kostopoulos IV; Kossiva L; Tzoumaka-Bakoula C; Pavlidis D; Filippidou M; Katsibardi K; Ampatzidou M; Kattamis A; Polychronopoulou S; Mantzourani M; Papadhimitriou SI
Leuk Lymphoma; 2022 Mar; 63(3):551-561. PubMed ID: 34727830
[TBL] [Abstract][Full Text] [Related]
2. Sequential karyotyping in Burkitt lymphoma reveals a linear clonal evolution with increase in karyotype complexity and a high frequency of recurrent secondary aberrations.
Aukema SM; Theil L; Rohde M; Bauer B; Bradtke J; Burkhardt B; Bonn BR; Claviez A; Gattenlöhner S; Makarova O; Nagel I; Oschlies I; Pott C; Szczepanowski M; Traulsen A; Kluin PM; Klapper W; Siebert R; Murga Penas EM
Br J Haematol; 2015 Sep; 170(6):814-25. PubMed ID: 26104998
[TBL] [Abstract][Full Text] [Related]
3. High-grade B-cell lymphoma with concurrent MYC rearrangement and 11q aberrations: clinicopathologic, cytogenetic, and molecular characterization of 4 cases.
Shestakova A; Shao L; Smith LB; Ryan R; Bedell V; Murata-Collins J; Zhang W; Perry AM; Song JY
Hum Pathol; 2023 Jun; 136():34-43. PubMed ID: 36997031
[TBL] [Abstract][Full Text] [Related]
4. Patterns of genomic aberrations suggest that Burkitt lymphomas with complex karyotype are distinct from other aggressive B-cell lymphomas with MYC rearrangement.
Havelange V; Ameye G; Théate I; Callet-Bauchu E; Mugneret F; Michaux L; Dastugue N; Penther D; Barin C; Collonge-Rame MA; Baranger L; Terré C; Nadal N; Lippert E; Laï JL; Cabrol C; Tigaud I; Herens C; Hagemeijer A; Raphael M; Libouton JM; Poirel HA;
Genes Chromosomes Cancer; 2013 Jan; 52(1):81-92. PubMed ID: 23012230
[TBL] [Abstract][Full Text] [Related]
5. An increased frequency of 13q deletions detected by fluorescence in situ hybridization and its impact on survival in children and adolescents with Burkitt lymphoma: results from the Children's Oncology Group study CCG-5961.
Nelson M; Perkins SL; Dave BJ; Coccia PF; Bridge JA; Lyden ER; Heerema NA; Lones MA; Harrison L; Cairo MS; Sanger WG
Br J Haematol; 2010 Feb; 148(4):600-10. PubMed ID: 19895612
[TBL] [Abstract][Full Text] [Related]
6. B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.
Snuderl M; Kolman OK; Chen YB; Hsu JJ; Ackerman AM; Dal Cin P; Ferry JA; Harris NL; Hasserjian RP; Zukerberg LR; Abramson JS; Hochberg EP; Lee H; Lee AI; Toomey CE; Sohani AR
Am J Surg Pathol; 2010 Mar; 34(3):327-40. PubMed ID: 20118770
[TBL] [Abstract][Full Text] [Related]
7. Prognostic power of abnormal cytogenetics for multiple myeloma: a multicenter study in China.
Lai YY; Huang XJ; Cai Z; Cao XS; Chen FP; Chen XQ; Chen BA; Fang MY; Feng JF; Fu WL; Guo HY; Hou M; Hou J; Hu Y; Hu XT; Hu XM; Huang LQ; Jin J; Li JY; Li J; Li W; Liang YM; Liu T; Liu QF; Liu YH; Mao P; Ouyang J; Qiu LG; Qiu L; Shao CK; Shi B; Song YP; Sun ZM; Wang QS; Wang C; Wang JM; Wang YS; Wang Z; Wu JB; Wu YX; Xia RX; Xue YQ; Yang BZ; Yang G; Yang ZL; Yu L; Yuan Z; Zhang S; Zhang Y; Zhao HG; Zhao L; Zhou DB; Zou SH; Zhu YF
Chin Med J (Engl); 2012 Aug; 125(15):2663-70. PubMed ID: 22931972
[TBL] [Abstract][Full Text] [Related]
8. Burkitt lymphoma (BL): reclassification of 39 lymphomas diagnosed as BL or Burkitt-like lymphoma in the past based on immunohistochemistry and fluorescence in situ hybridization.
Kodet R; Mrhalová M; Stejskalová E; Kabícková E
Cesk Patol; 2011 Jul; 47(3):106-14. PubMed ID: 21887927
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive cytogenetic and molecular cytogenetic analysis of 44 Burkitt lymphoma cell lines: secondary chromosomal changes characterization, karyotypic evolution, and comparison with primary samples.
Maria Murga Penas E; Schilling G; Behrmann P; Klokow M; Vettorazzi E; Bokemeyer C; Dierlamm J
Genes Chromosomes Cancer; 2014 Jun; 53(6):497-515. PubMed ID: 24590883
[TBL] [Abstract][Full Text] [Related]
10. Molecular cytogenetic aberrations in patients with multiple myeloma studied by interphase fluorescence in situ hybridization.
Chen L; Li J; Xu W; Qiu H; Zhu Y; Zhang Y; Duan L; Qian S; Lu H
Exp Oncol; 2007 Jun; 29(2):116-20. PubMed ID: 17704743
[TBL] [Abstract][Full Text] [Related]
11. [Fluorescence in situ hybridization in the diagnosis of aggressive B-cell lymphomas].
Gerhard-Hartmann E; Rosenwald A
Pathologe; 2020 Nov; 41(6):574-581. PubMed ID: 32909092
[TBL] [Abstract][Full Text] [Related]
12. Application of 2016 WHO classification in the diagnosis of paediatric high-grade
Zhang L; Brown LE; Bowen LM; McCarthy LC; Cooley LD; Repnikova E; Gener MA; Garola R; August KJ; Hays JA; Zwick DL; Li W
J Clin Pathol; 2020 Sep; 73(9):563-570. PubMed ID: 31964683
[TBL] [Abstract][Full Text] [Related]
13. [Round robin test for detection of genomic aberrations in non-Hodgkin lymphoma by in situ hybridization].
Barth TF; Floßbach L; Bernd HW; Bob R; Buck M; Cogliatti SB; Feller AC; Hansmann ML; Hartmann S; Horn H; Klapper W; Kradolfer D; Mattfeldt T; Möller P; Rosenwald A; Stein H; Thorns C; Ott G
Pathologe; 2013 Jul; 34(4):329-34. PubMed ID: 23179209
[TBL] [Abstract][Full Text] [Related]
14. Non-Hodgkin's lymphomas with Burkitt-like cells are associated with c-Myc amplification and poor prognosis.
Mossafa H; Damotte D; Jenabian A; Delarue R; Vincenneau A; Amouroux I; Jeandel R; Khoury E; Martelli JM; Samson T; Tapia S; Flandrin G; Troussard X
Leuk Lymphoma; 2006 Sep; 47(9):1885-93. PubMed ID: 17065002
[TBL] [Abstract][Full Text] [Related]
15. Novel three-break rearrangement and cryptic translocations leading to colocalization of MYC and IGH signals in B-cell acute lymphoblastic leukemia.
Tchinda J; Volpert S; Berdel WE; Büchner T; Horst J
Cancer Genet Cytogenet; 2006 Mar; 165(2):180-4. PubMed ID: 16527615
[TBL] [Abstract][Full Text] [Related]
16. Cryptic MYC insertions in Burkitt lymphoma: New data and a review of the literature.
Woroniecka R; Rymkiewicz G; Szafron LM; Blachnio K; Szafron LA; Bystydzienski Z; Pienkowska-Grela B; Borkowska K; Rygier J; Kotyl A; Malawska N; Wojtkowska K; Parada J; Borysiuk A; Murcia Pienkowski V; Rydzanicz M; Grygalewicz B
PLoS One; 2022; 17(2):e0263980. PubMed ID: 35167621
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic challenges in a case of B cell lymphoma unclassifiable with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma.
So CC; Yung KH; Chu ML; Wan TS
Int J Hematol; 2013 Oct; 98(4):478-82. PubMed ID: 23959583
[TBL] [Abstract][Full Text] [Related]
18. An extended fluorescence in situ hybridization approach for the cytogenetic study of cholangiocarcinoma on endoscopic retrograde cholangiopancreatography brushing cytology preparations.
Vasilieva LE; Papadhimitriou SI; Alexopoulou A; Pavlidis D; Kostopoulos I; Georgiakaki M; Xinopoulos D; Romanos A; Dourakis SP
Hum Pathol; 2013 Oct; 44(10):2173-9. PubMed ID: 23845469
[TBL] [Abstract][Full Text] [Related]
19. Supernumerary isochromosome 1, idic(1)(p12), leading to tetrasomy 1q in Burkitt lymphoma.
Roug AS; Wendtland P; Bendix K; Kjeldsen E
Cytogenet Genome Res; 2014; 142(1):7-13. PubMed ID: 24217199
[TBL] [Abstract][Full Text] [Related]
20. Chromosomal aberrations evaluated by CGH, FISH and GTG-banding in a case of AIDS-related Burkitt's lymphoma.
Zunino A; Viaggi S; Ottaggio L; Fronza G; Schenone A; Roncella S; Abbondandolo A
Haematologica; 2000 Mar; 85(3):250-5. PubMed ID: 10702812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
